New test aims to improve doctor decisions for chronic illness
NCT ID NCT05192590
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a new test (CDMT) helps primary care doctors make better decisions for patients with cardiometabolic syndrome. 247 board-certified physicians participated, with some using the test and others not. Researchers measured the quality of care and expected costs to see if the test improves patient management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
QURE Healthcare
San Francisco, California, 94109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wine grape leftovers could be a Heart-Healthy superfood
- Could dimming lights and early dinners boost insulin sensitivity?
- New shot may lower heart risk in patients whose medications block statins
- Weekend catch-up sleep may not undo damage from short sleep during the week
- Could an antibody fight both psoriasis and heart disease?
- New lifestyle program aims to boost fitness in older adults at heart risk